Background and objective: Cancer and diabetes are two highly prevalent diseases worldwide and influence the quality of life. The study aimed to compare the quality of life in patients diagnosed with cancer and diabetes with those without diabetes undergoing chemotherapy and to investigate the responsible factors. Method: A convenience sample of 101 participants that had cancer and diabetes type 2 and 99 had cancer without diabetes, were used. Results: Patients with comorbid diabetes were divided based on their diabetes duration and whether they had glycemic control or not. Diabetic cancer patients without glycemic control had lower scores in global health status in physical and emotional functioning compared to diabetic cancer patients with glycemic control and patients without diabetes (p < .05). After adjusting for demographic characteristics, the differences between the group with diabetes and without glycemic control and the other two groups on global health status were statistically significant (p < .05). Patients with over 7 years of diabetes had a statistically significantly lower emotional functioning than the no diabetes group and lower global health status score that both of the other groups (p < .05). After adjusting for clinical and demographic characteristics, only the difference between the ≥ 7 years diabetes duration group and the no diabetes groups remained significant. Conclusion: The presence of diabetes in cancer patients underwent chemotherapy seems to negatively influence certain domains of quality of life and this seems to be affected by the duration of diabetes and whether glycemic control has been achieved.

No abstract

No abstract

No abstract

No abstract